Dysbiosis in the Gut Bacterial Microbiome of Patients with Uveitis, an Inflammatory Disease of the Eye
Sama Kalyana Chakravarthy, Rajagopalaboopathi Jayasudha, Gumpili Sai Prashanthi, Mohammed Hasnat Ali, Savitri Sharma, Mudit Tyagi, Sisinthy Shivaji, Sama Kalyana Chakravarthy, Rajagopalaboopathi Jayasudha, Gumpili Sai Prashanthi, Mohammed Hasnat Ali, Savitri Sharma, Mudit Tyagi, Sisinthy Shivaji
Abstract
Uveitis (UVT), an inflammatory disease of the eye significantly contributes to vision impairment and blindness. Uveitis is associated with systemic infectious and autoimmune diseases, but in most cases, the aetiology remains unidentified. Dysbiosis in the gut microbiome has been implicated in autoimmune diseases, inflammatory diseases, cancers and mental disorders. In a mice model of autoimmune UVT, it was observed that manipulating the gut microbiome reduces the inflammation and disease severity. Further, alterations in the bacterial gut microbiome and their metabolites were reported in UVT patients from a Chinese cohort. Hence, it is worth comparing the bacterial gut microbiome of UVT patients with that of healthy controls (HC) to ascertain whether dysbiosis of the gut microbiome has implications in UVT. Our analyses showed reduced diversity of several anti-inflammatory organisms including Faecalibacterium, Bacteroides, Lachnospira, Ruminococcus and members of Lachnospiraceae and Ruminococcaceae families, and enrichment of Prevotella (proinflammatory) and Streptococcus (pathogenic) OTUs in UVT microbiomes compared to HC. In addition, decrease in probiotic and antibacterial organisms was observed in UVT compared to HC microbiomes. Heatmap and PCoA plots also indicated significant variations in the microbiomes of UVT versus HC. This is the first study demonstrating dysbiosis in the gut bacterial communities of UVT patients in an Indian cohort and suggests a role of the gut microbiome in the pathophysiology of UVT.
Keywords: Dysbiosis; Gut microbiome; Illumina Miseq; Uveitis; V3–V4 region of 16S rRNA gene.
Conflict of interest statement
The authors declare that they have no conflict of interest.Informed consent was taken from all the study subjects prior to sample collection. The study protocols were approved by the Institutional Review Board of L. V. Prasad Eye Institute, Hyderabad (Ethics Ref. No. LEC 06-14-060) and all methods were performed in accordance with relevant guidelines and regulations.
Figures
![Fig. 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6141402/bin/12088_2018_746_Fig1_HTML.jpg)
![Fig. 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6141402/bin/12088_2018_746_Fig2_HTML.jpg)
![Fig. 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6141402/bin/12088_2018_746_Fig3_HTML.jpg)
![Fig. 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6141402/bin/12088_2018_746_Fig4a_HTML.jpg)
![Fig. 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6141402/bin/12088_2018_746_Fig4b_HTML.jpg)
Source: PubMed